{"pmid":32426311,"pmcid":"PMC7203211","title":"Novel Coronavirus Disease 2019 Infection in Children: The Dark Side of a Worldwide Outbreak.","text":["Novel Coronavirus Disease 2019 Infection in Children: The Dark Side of a Worldwide Outbreak.","In this pediatric perspectives article, we discuss current limits in the understanding of novel coronavirus infection. In our opinion, the burden of novel coronavirus infections is underestimated because not actively looked for. We discuss the basis of our observations and what this can generate, suggesting a different approach for the search of the virus in children.","Front Pediatr","Buonsenso, Danilo","Zampino, Giuseppe","Valentini, Piero","32426311"],"abstract":["In this pediatric perspectives article, we discuss current limits in the understanding of novel coronavirus infection. In our opinion, the burden of novel coronavirus infections is underestimated because not actively looked for. We discuss the basis of our observations and what this can generate, suggesting a different approach for the search of the virus in children."],"journal":"Front Pediatr","authors":["Buonsenso, Danilo","Zampino, Giuseppe","Valentini, Piero"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32426311","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.3389/fped.2020.00215","keywords":["covid-19","sars-cov-2","children","coronavirus","public health"],"topics":["Prevention"],"weight":1,"_version_":1667352728779620352,"score":9.490897,"similar":[{"pmid":32112072,"pmcid":"PMC7108143","title":"A Case Series of children with 2019 novel coronavirus infection: clinical and epidemiological features.","text":["A Case Series of children with 2019 novel coronavirus infection: clinical and epidemiological features.","We first described the 2019 novel coronavirus infection in 10 children occurring in areas other than Wuhan. The coronavirus diseases in children are usually mild and epidemiological exposure is a key clue to recognize pediatric case. Prolonged virus shedding is observed in respiratory tract and feces at the convalescent stage.","Clin Infect Dis","Cai, Jiehao","Xu, Jing","Lin, Daojiong","Yang, Zhi","Xu, Lei","Qu, Zhenghai","Zhang, Yuehua","Zhang, Hua","Jia, Ran","Liu, Pengcheng","Wang, Xiangshi","Ge, Yanling","Xia, Aimei","Tian, He","Chang, Hailing","Wang, Chuning","Li, Jingjing","Wang, Jianshe","Zeng, Mei","32112072"],"abstract":["We first described the 2019 novel coronavirus infection in 10 children occurring in areas other than Wuhan. The coronavirus diseases in children are usually mild and epidemiological exposure is a key clue to recognize pediatric case. Prolonged virus shedding is observed in respiratory tract and feces at the convalescent stage."],"journal":"Clin Infect Dis","authors":["Cai, Jiehao","Xu, Jing","Lin, Daojiong","Yang, Zhi","Xu, Lei","Qu, Zhenghai","Zhang, Yuehua","Zhang, Hua","Jia, Ran","Liu, Pengcheng","Wang, Xiangshi","Ge, Yanling","Xia, Aimei","Tian, He","Chang, Hailing","Wang, Chuning","Li, Jingjing","Wang, Jianshe","Zeng, Mei"],"date":"2020-03-01T11:00:00Z","year":2020,"_id":"32112072","source":"PubMed","week":"20209|Feb 24 - Mar 01","doi":"10.1093/cid/ciaa198","keywords":["2019 novel coronavirus","children","coronavirus diseases"],"locations":["Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1666138492856434688,"score":103.07018},{"pmid":32476394,"title":"[Otorhinolaryngological aspects of the disease course in children infected with SARS-CoV-2 virus].","text":["[Otorhinolaryngological aspects of the disease course in children infected with SARS-CoV-2 virus].","Recently, almost all over the world attention of doctors and scientists is focused on a new coronavirus infection, the source of which was the causative agent SARS-CoV-2. In this regard, early diagnosis, including on the basis of symptoms from ENT organs, is crucial. A brief analysis of the available literature on the peculiarities of ENT organs manifestations in patients with SARS-CoV-2 is given. It was found out that to date there is very little data on the state of loro organs in patients with SARS-CoV-2 and no data on anosmia in the pediatric population. However, it is in children in the epidemic aspect that early diagnosis of infection and understanding of its key symptoms is of utmost importance.","Vestn Otorinolaringol","Rusetsky, Yu Yu","MeYtel, I Yu","Babayan, A R","Malyavina, U S","32476394"],"abstract":["Recently, almost all over the world attention of doctors and scientists is focused on a new coronavirus infection, the source of which was the causative agent SARS-CoV-2. In this regard, early diagnosis, including on the basis of symptoms from ENT organs, is crucial. A brief analysis of the available literature on the peculiarities of ENT organs manifestations in patients with SARS-CoV-2 is given. It was found out that to date there is very little data on the state of loro organs in patients with SARS-CoV-2 and no data on anosmia in the pediatric population. However, it is in children in the epidemic aspect that early diagnosis of infection and understanding of its key symptoms is of utmost importance."],"journal":"Vestn Otorinolaringol","authors":["Rusetsky, Yu Yu","MeYtel, I Yu","Babayan, A R","Malyavina, U S"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32476394","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.17116/otorino20208502163","keywords":["ent","sars-cov-2","anosmia","children","coronavirus"],"topics":["Diagnosis"],"weight":1,"_version_":1668532089532710913,"score":99.17701},{"pmid":32382748,"title":"Lessons from COVID-19 in children: Key hypotheses to guide preventative and therapeutic strategies.","text":["Lessons from COVID-19 in children: Key hypotheses to guide preventative and therapeutic strategies.","The current pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), reveals a peculiar trend of milder disease and lower case fatality in children compared to adults. Consistent epidemiologic evidence of reduced severity of infection in children across different populations and countries suggests there are underlying biologic differences between children and adults that mediate differential disease pathogenesis. This presents a unique opportunity to learn about disease modifying host factors from pediatric populations. Our review summarizes the current knowledge of pediatric clinical disease, role in transmission, risks for severe disease, protective immunity, as well as novel therapies and vaccine trials for children. We then define key hypotheses and areas for future research that can use the pediatric model of disease, transmission, and immunity to develop preventive and therapeutic strategies for people of all age groups.","Clin Infect Dis","Singh, Tulika","Heston, Sarah M","Langel, Stephanie N","Blasi, Maria","Hurst, Jillian H","Fouda, Genevieve G","Kelly, Matthew S","Permar, Sallie R","32382748"],"abstract":["The current pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), reveals a peculiar trend of milder disease and lower case fatality in children compared to adults. Consistent epidemiologic evidence of reduced severity of infection in children across different populations and countries suggests there are underlying biologic differences between children and adults that mediate differential disease pathogenesis. This presents a unique opportunity to learn about disease modifying host factors from pediatric populations. Our review summarizes the current knowledge of pediatric clinical disease, role in transmission, risks for severe disease, protective immunity, as well as novel therapies and vaccine trials for children. We then define key hypotheses and areas for future research that can use the pediatric model of disease, transmission, and immunity to develop preventive and therapeutic strategies for people of all age groups."],"journal":"Clin Infect Dis","authors":["Singh, Tulika","Heston, Sarah M","Langel, Stephanie N","Blasi, Maria","Hurst, Jillian H","Fouda, Genevieve G","Kelly, Matthew S","Permar, Sallie R"],"date":"2020-05-09T11:00:00Z","year":2020,"_id":"32382748","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1093/cid/ciaa547","keywords":["covid-19","children","pediatrics","sars-cov-2","vaccines"],"topics":["Treatment","Prevention"],"weight":1,"_version_":1666267276777619456,"score":98.666016},{"pmid":32418216,"title":"Children with Coronavirus Disease 2019 (COVID-19): A Review of Demographic, Clinical, Laboratory and Imaging Features in 2,597 Pediatric Patients.","text":["Children with Coronavirus Disease 2019 (COVID-19): A Review of Demographic, Clinical, Laboratory and Imaging Features in 2,597 Pediatric Patients.","An epidemic of coronavirus disease 2019 (COVID-19) has been spreading worldwide. With the rapid increase in the number of infections, children with COVID-19 appear to be rising. Most research findings regarding adult cases, which are not always transferrable to children. Evidence-based studies are still expected to formulate clinical decisions for pediatric patients. In this review, we evaluated the demographic, clinical, laboratory and imaging features from 2,597 pediatric patients of COVID-19 that reported recently. We found that even lymphopenia was the most common lab finding in adults, it infrequently occurred in children (9.8%). Moreover, elevated creatine kinase MB isoenzyme (CK-MB) was much more commonly observed in children (27.0%) than that in adults, suggesting that heart injury would be more likely to happen in pediatric patients. Our analysis may contribute to determine the spectrum of disease in children, as well as to develop strategies to control the disease transmission. This article is protected by copyright. All rights reserved.","J Med Virol","Cui, Xiaojian","Zhang, Tongqiang","Zheng, Jiafeng","Zhang, Jiayi","Si, Ping","Xu, Yongsheng","Guo, Wei","Liu, Zihui","Li, Wenliang","Ma, Jia","Dong, Cuicui","Shen, Yongming","Cai, Chunquan","He, Sijia","32418216"],"abstract":["An epidemic of coronavirus disease 2019 (COVID-19) has been spreading worldwide. With the rapid increase in the number of infections, children with COVID-19 appear to be rising. Most research findings regarding adult cases, which are not always transferrable to children. Evidence-based studies are still expected to formulate clinical decisions for pediatric patients. In this review, we evaluated the demographic, clinical, laboratory and imaging features from 2,597 pediatric patients of COVID-19 that reported recently. We found that even lymphopenia was the most common lab finding in adults, it infrequently occurred in children (9.8%). Moreover, elevated creatine kinase MB isoenzyme (CK-MB) was much more commonly observed in children (27.0%) than that in adults, suggesting that heart injury would be more likely to happen in pediatric patients. Our analysis may contribute to determine the spectrum of disease in children, as well as to develop strategies to control the disease transmission. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Cui, Xiaojian","Zhang, Tongqiang","Zheng, Jiafeng","Zhang, Jiayi","Si, Ping","Xu, Yongsheng","Guo, Wei","Liu, Zihui","Li, Wenliang","Ma, Jia","Dong, Cuicui","Shen, Yongming","Cai, Chunquan","He, Sijia"],"date":"2020-05-18T11:00:00Z","year":2020,"_id":"32418216","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1002/jmv.26023","keywords":["2019-ncov","covid-19","children","pediatric patients","sars-cov-2"],"topics":["Diagnosis"],"weight":1,"_version_":1667058206829969408,"score":96.23614},{"pmid":32381073,"title":"A child with household transmitted COVID-19.","text":["A child with household transmitted COVID-19.","BACKGROUND: Although people of all ages are susceptible to the novel coronavirus infection, which is presently named \"Coronavirus Disease 2019\" (COVID-19), there has been relatively few cases reported among children. Therefore, it is necessary to understand the clinical characteristics of COVID-19 in children and the differences from adults. CASE PRESENTATION: We report one pediatric case of COVID-19. A 14-month-old boy was admitted to the hospital with a symptom of fever, and was diagnosed with a mild form of COVID-19. The child's mother and grandmother also tested positive for SARS-CoV-2 RNA. However, the lymphocyte counts were normal. The chest computed tomography (CT) revealed scattered ground glass opacities in the right lower lobe close to the pleura and resorption after the treatment. The patient continued to test positive for SARS-CoV-2 RNA in the nasopharyngeal swabs and stool at 17 days after the disappearance of symptoms. CONCLUSION: The present pediatric case of COVID-19 was acquired through household transmission, and the symptoms were mild. Lymphocyte counts did not significantly decrease. The RNA of SARS-CoV-2 in stool and nasopharyngeal swabs remained positive for an extended period of time after the disappearance of symptoms. This suggests that attention should be given to the potential contagiousness of pediatric COVID-19 cases after clinical recovery.","BMC Infect Dis","Mao, Li-Juan","Xu, Jian","Xu, Zhi-Hao","Xia, Xiao-Ping","Li, Bin","He, Jian-Guo","Zhao, Peng","Pan, Jian-Wei","Zhang, Dan","Su, Yue","Wang, Yue-Hong","Yuan, Zhe-Feng","32381073"],"abstract":["BACKGROUND: Although people of all ages are susceptible to the novel coronavirus infection, which is presently named \"Coronavirus Disease 2019\" (COVID-19), there has been relatively few cases reported among children. Therefore, it is necessary to understand the clinical characteristics of COVID-19 in children and the differences from adults. CASE PRESENTATION: We report one pediatric case of COVID-19. A 14-month-old boy was admitted to the hospital with a symptom of fever, and was diagnosed with a mild form of COVID-19. The child's mother and grandmother also tested positive for SARS-CoV-2 RNA. However, the lymphocyte counts were normal. The chest computed tomography (CT) revealed scattered ground glass opacities in the right lower lobe close to the pleura and resorption after the treatment. The patient continued to test positive for SARS-CoV-2 RNA in the nasopharyngeal swabs and stool at 17 days after the disappearance of symptoms. CONCLUSION: The present pediatric case of COVID-19 was acquired through household transmission, and the symptoms were mild. Lymphocyte counts did not significantly decrease. The RNA of SARS-CoV-2 in stool and nasopharyngeal swabs remained positive for an extended period of time after the disappearance of symptoms. This suggests that attention should be given to the potential contagiousness of pediatric COVID-19 cases after clinical recovery."],"journal":"BMC Infect Dis","authors":["Mao, Li-Juan","Xu, Jian","Xu, Zhi-Hao","Xia, Xiao-Ping","Li, Bin","He, Jian-Guo","Zhao, Peng","Pan, Jian-Wei","Zhang, Dan","Su, Yue","Wang, Yue-Hong","Yuan, Zhe-Feng"],"date":"2020-05-09T11:00:00Z","year":2020,"_id":"32381073","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1186/s12879-020-05056-w","keywords":["covid-19","children","sars-cov-2"],"topics":["Case Report"],"weight":1,"_version_":1666267276712607744,"score":92.76692}]}